Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79


Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PW, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP.

J Clin Oncol. 2014 May 20;32(15):1563-70. doi: 10.1200/JCO.2013.51.2046. Epub 2014 Mar 17. Erratum in: J Clin Oncol. 2014 Oct 20;32(30):3462.


Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators.

Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22.


Topotecan and cyclophosphamide in adults with relapsed sarcoma.

Blanchette P, Hogg D, Ferguson P, Wunder JS, Swallow C, Gladdy R, Chung P, O'Sullivan B, Blackstein ME, Catton C, Gupta AA.

Sarcoma. 2012;2012:749067. doi: 10.1155/2012/749067. Epub 2012 Jul 18.


A thematic review of scientific and family interests in Canavan Disease: where are the developmentalists?

Glicksman S, Borgen C, Blackstein M, Gordon A, Hanon I, Kusin D, Leibowitz B, Halle J.

J Intellect Disabil Res. 2013 Sep;57(9):815-25. doi: 10.1111/j.1365-2788.2012.01576.x. Epub 2012 Jun 8. Review.


Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution Experience.

Weiss KR, Biau DJ, Bhumbra R, Griffin AM, Blackstein ME, Chung P, Catton C, O'Sullivan B, Ferguson PC, Wunder JS.

Sarcoma. 2011;2011:395180. doi: 10.1155/2011/395180. Epub 2011 Nov 24.


Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

Al-Hussaini H, Hogg D, Blackstein ME, O'Sullivan B, Catton CN, Chung PW, Griffin AM, Hodgson D, Hopyan S, Kandel R, Ferguson PC, Wunder JS, Gupta AA.

Sarcoma. 2011;2011:231789. doi: 10.1155/2011/231789. Epub 2011 Apr 14.


Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.

Blay JY, von Mehren M, Blackstein ME.

Cancer. 2010 Nov 15;116(22):5126-37. doi: 10.1002/cncr.25267. Review.


Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy.

Gupta AA, Pappo A, Saunders N, Hopyan S, Ferguson P, Wunder J, O'Sullivan B, Catton C, Greenberg M, Blackstein M.

Cancer. 2010 Jul 1;116(13):3189-94. doi: 10.1002/cncr.25144.


Painful palatal swelling.

Klieb HB, Duchnay M, Skeete D, Leong IT, Blackstein ME.

Lancet. 2010 Apr 3;375(9721):1224. doi: 10.1016/S0140-6736(10)60053-0. No abstract available.


Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure.

Deprimo SE, Huang X, Blackstein ME, Garrett CR, Harmon CS, Schöffski P, Shah MH, Verweij J, Baum CM, Demetri GD.

Clin Cancer Res. 2009 Sep 15;15(18):5869-77. doi: 10.1158/1078-0432.CCR-08-2480. Epub 2009 Sep 8.


Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.

Toms AP, White LM, Kandel R, Bleakney RR, Noseworthy M, Lee S, Blackstein ME, Wunder J.

Acta Radiol. 2009 Jun;50(5):512-20. doi: 10.1080/02841850902922761.


Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K; American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team.

Lancet. 2009 Mar 28;373(9669):1097-104. doi: 10.1016/S0140-6736(09)60500-6. Epub 2009 Mar 18. Erratum in: Lancet. 2009 Aug 8;374(9688):450.


Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases.

Aljubran AH, Griffin A, Pintilie M, Blackstein M.

Ann Oncol. 2009 Jun;20(6):1136-41. doi: 10.1093/annonc/mdn731. Epub 2009 Jan 19.


Rectal gastrointestinal stromal tumor mimicking a primary prostatic lesion.

Dickson BC, Srigley JR, Pollett AF, Blackstein ME, Honey JD, Juco JW.

Can J Urol. 2008 Jun;15(3):4112-4.


A Phase II Study of Docetaxel in Chemotherapy-Naïve Patients With Recurrent or Metastatic Adult Soft Tissue Sarcoma.

Bramwell V, Blackstein M, Belanger K, Verma S, Beare S, Eisenhauer E.

Sarcoma. 1998;2(1):29-33. doi: 10.1080/13577149878136.


Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii89-93. doi: 10.1093/annonc/mdn101. No abstract available.


Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii35-8. doi: 10.1093/annonc/mdn080. No abstract available.


Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.

Verma S, Younus J, Haynes AE, Stys-Norman D, Blackstein M; Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

Curr Oncol. 2008 Apr;15(2):80-4.


The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: the example of sunitinib for gastrointestinal stromal tumour.

Chabot I, LeLorier J, Blackstein ME.

Eur J Cancer. 2008 May;44(7):972-7. doi: 10.1016/j.ejca.2008.02.041. Epub 2008 Mar 26.


Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.

Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Members of the Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care.

Cancer Treat Rev. 2008 Jun;34(4):339-47. doi: 10.1016/j.ctrv.2008.01.005. Epub 2008 Mar 3.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk